Deerfield Beach, FL -- (SBWIRE) -- 09/21/2015 -- About Glaucoma Therapeutics

Glaucoma is a disease of the eye in which fluid pressure within the eye increases. If left untreated the patient may lose vision and even become blind. Global Glaucoma Therapeutics market will grow at a CAGR of 2.53% over the period 2013-2018. The exact etiology of optic nerve damage due to glaucoma is not fully known, but involves mechanical compression and/or decreased blood flow in the optic nerve. Based on whether the cause of the disease is unknown or known, glaucoma is divided into two types, open angle and closed angle glaucoma. Five main classes of medical treatment are currently used to lower intraocular pressure: prostaglandins, beta blockers, alpha adrenergic agonists, carbonic anhydrase inhibitors, and fixed dose combinations.

Read More Info About Report @ http://www.marketresearchstore.com/report/global-glaucoma-therapeutics-market-2014-2018-10773

Covered in this Report

The Global Glaucoma Therapeutics market can be divided into five segments: Prostaglandins, Beta Blockers, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, and Fixed Dose Combinations. To calculate the market size, the report considers the revenue generated from the sales of various ophthalmic solutions used in the treatment of glaucoma. The report, the Global Glaucoma Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Glaucoma Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

- Americas
- EMEA
- APAC

Key Vendors

- Allergan Inc.
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.

Enquiry Before Buying @ http://www.marketresearchstore.com/report/global-glaucoma-therapeutics-market-2014-2018-10773#reportPriceDetails

Other Prominent Vendors

- Acadia Pharmaceuticals Inc.
- AC Immune SA
- Acorn Biomedical Inc.
- Advanced Cell Technology Inc.
- Aerie Pharmaceuticals Inc.
- Carl Zeiss Meditec Inc.
- Falcon Pharmaceuticals Ltd.
- Inotek Pharmaceuticals Corp.
- Lexicon Pharmaceuticals Inc.
- Neurotech Pharmaceuticals Inc.
- NicOx SA
- Otsuka Holdings Co. Ltd.
- Phytopharm plc
- Santen Pharmaceuticals Co. Ltd.
- Senju Pharmaceutical Co. Ltd.
- SIFI SpA
- Valeant Pharmaceuticals International Inc.

Important Questions Answered in report:-

What will the expected Compound Annual Growth Rate For "Glaucoma Therapeutics Market"?
What will the Glaucoma Therapeutics Market size be in 2019?
What is driving this market?
What are the challenges related to Glaucoma Therapeutics Market growth?
What are the key market trends?
Who are the key vendors in Glaucoma Therapeutics Market area?
What are the market opportunities?
What are the strengths as well as weaknesses of the key vendors?
Which are the threats faced by the key vendors?